About Hannah Chang
Form D filings for Ray Therapeutics in 2023 list Hannah Chang as director.
Hannah Chang first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Hannah Chang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Hannah Chang works with at each company, as listed on that company's latest Form D.
Ray Therapeutics, Inc. · Form D, May 26, 2023
TA
Tiba Aynechi
Director
DK
Dmitry Kuzmin
Director
SA
Sean Ainsworth
Executive officer and director
RC
Raymond Camahort
Director
GA
Gary Abrams
Director
PB
Paul Bresge
Chief Executive Officer and director